Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation. / Sellebjerg, F.; Krakauer, M.; Hesse, D.; Ryder, L.P.; Alsing, I.; Jensen, P.E.; Koch-Henriksen, N.; Svejgaard, A.; Sorensen, P. Soelberg; Sellebjerg, Finn Thorup; Krakauer, M; Hesse, D; Ryder, L P; Alsing, I; Jensen, P E H; Koch-Henriksen, Nils; Svejgaard, Anja; Sørensen, Per Soelberg.

I: European Journal of Neurology, Bind 16, Nr. 12, 2009, s. 1291-8.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Sellebjerg, F, Krakauer, M, Hesse, D, Ryder, LP, Alsing, I, Jensen, PE, Koch-Henriksen, N, Svejgaard, A, Sorensen, PS, Sellebjerg, FT, Krakauer, M, Hesse, D, Ryder, LP, Alsing, I, Jensen, PEH, Koch-Henriksen, N, Svejgaard, A & Sørensen, PS 2009, 'Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation', European Journal of Neurology, bind 16, nr. 12, s. 1291-8. https://doi.org/10.1111/j.1468-1331.2009.02716.x, https://doi.org/10.1111/j.1468-1331.2009.02716.x

APA

Sellebjerg, F., Krakauer, M., Hesse, D., Ryder, L. P., Alsing, I., Jensen, P. E., Koch-Henriksen, N., Svejgaard, A., Sorensen, P. S., Sellebjerg, F. T., Krakauer, M., Hesse, D., Ryder, L. P., Alsing, I., Jensen, P. E. H., Koch-Henriksen, N., Svejgaard, A., & Sørensen, P. S. (2009). Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation. European Journal of Neurology, 16(12), 1291-8. https://doi.org/10.1111/j.1468-1331.2009.02716.x, https://doi.org/10.1111/j.1468-1331.2009.02716.x

Vancouver

Sellebjerg F, Krakauer M, Hesse D, Ryder LP, Alsing I, Jensen PE o.a. Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation. European Journal of Neurology. 2009;16(12):1291-8. https://doi.org/10.1111/j.1468-1331.2009.02716.x, https://doi.org/10.1111/j.1468-1331.2009.02716.x

Author

Sellebjerg, F. ; Krakauer, M. ; Hesse, D. ; Ryder, L.P. ; Alsing, I. ; Jensen, P.E. ; Koch-Henriksen, N. ; Svejgaard, A. ; Sorensen, P. Soelberg ; Sellebjerg, Finn Thorup ; Krakauer, M ; Hesse, D ; Ryder, L P ; Alsing, I ; Jensen, P E H ; Koch-Henriksen, Nils ; Svejgaard, Anja ; Sørensen, Per Soelberg. / Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation. I: European Journal of Neurology. 2009 ; Bind 16, Nr. 12. s. 1291-8.

Bibtex

@article{9884b6c0631d11df928f000ea68e967b,
title = "Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation",
abstract = "Neutralizing antibodies (NAbs) occur in a proportion of multiple sclerosis (MS) patients treated with interferon (IFN)-beta. NAbs impair the effect of treatment. The biological effect of IFN-beta can be measured as the induction of the myxovirus resistance protein A (MxA) molecule. However, other markers could be more sensitive for evaluating the response to IFN-beta. We used DNA array analysis to identify genes that are strongly induced in blood cells by IFN-beta, and measured their expression in MS patients with different NAb levels.",
author = "F. Sellebjerg and M. Krakauer and D. Hesse and L.P. Ryder and I. Alsing and P.E. Jensen and N. Koch-Henriksen and A. Svejgaard and Sorensen, {P. Soelberg} and Sellebjerg, {Finn Thorup} and M Krakauer and D Hesse and Ryder, {L P} and I Alsing and Jensen, {P E H} and Nils Koch-Henriksen and Anja Svejgaard and S{\o}rensen, {Per Soelberg}",
year = "2009",
doi = "10.1111/j.1468-1331.2009.02716.x",
language = "English",
volume = "16",
pages = "1291--8",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "12",

}

RIS

TY - JOUR

T1 - Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation

AU - Sellebjerg, F.

AU - Krakauer, M.

AU - Hesse, D.

AU - Ryder, L.P.

AU - Alsing, I.

AU - Jensen, P.E.

AU - Koch-Henriksen, N.

AU - Svejgaard, A.

AU - Sorensen, P. Soelberg

AU - Sellebjerg, Finn Thorup

AU - Krakauer, M

AU - Hesse, D

AU - Ryder, L P

AU - Alsing, I

AU - Jensen, P E H

AU - Koch-Henriksen, Nils

AU - Svejgaard, Anja

AU - Sørensen, Per Soelberg

PY - 2009

Y1 - 2009

N2 - Neutralizing antibodies (NAbs) occur in a proportion of multiple sclerosis (MS) patients treated with interferon (IFN)-beta. NAbs impair the effect of treatment. The biological effect of IFN-beta can be measured as the induction of the myxovirus resistance protein A (MxA) molecule. However, other markers could be more sensitive for evaluating the response to IFN-beta. We used DNA array analysis to identify genes that are strongly induced in blood cells by IFN-beta, and measured their expression in MS patients with different NAb levels.

AB - Neutralizing antibodies (NAbs) occur in a proportion of multiple sclerosis (MS) patients treated with interferon (IFN)-beta. NAbs impair the effect of treatment. The biological effect of IFN-beta can be measured as the induction of the myxovirus resistance protein A (MxA) molecule. However, other markers could be more sensitive for evaluating the response to IFN-beta. We used DNA array analysis to identify genes that are strongly induced in blood cells by IFN-beta, and measured their expression in MS patients with different NAb levels.

U2 - 10.1111/j.1468-1331.2009.02716.x

DO - 10.1111/j.1468-1331.2009.02716.x

M3 - Journal article

VL - 16

SP - 1291

EP - 1298

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 12

ER -

ID: 19819843